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modifiable risk factors, including smoking and cholesterol abnor-
malities.
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Mild Hypercholesterolemia
and Premature Heart Disease
In a recent study published in the Journal by Akosah et al. (1), the
investigators found that the presence of borderline or mild hyper-
cholesterolemia has significant effects on the development of
premature coronary heart disease.
In this way, a group of 229 male patients ,50 years of age
(mean age 43 6 5 years), who were admitted to our Coronary Care
Unit as a result of an episode of coronary disease were prospectively
studied. During the acute phase and by means of a structured
questionnaire, the presence of smoking habits, hypertension,
diabetes and dyslipemia were recorded. A physical examination
and fasting analysis were also done. Due to clinical instability or
persistent myocardial ischemia, 132 patients underwent a cardiac
catheterization. In accordance with a previous report (2) we
considered as normolipemia a total cholesterol/HDL cholesterol
ratio (Tchol/HDL) #5. Two groups were established on this
basis. To determine new coronary events, a mean follow-up of
32 6 13 months was carried out. For statistical analysis, the chi
square test and Fisher exact test were applied.
Our study was observational and did not suppose any interven-
tion in the treatment. In the acute phase we found that 160
patients (73%) were smokers; 84 (36%) presented arterial hyper-
tension; 21 (9%) had diabetes; and 181 (77%) had dyslipemia. In
the follow-up, 45 patients (20%) retained smoking habits; 76
(34%) had arterial hypertension; 22 (10%) had diabetes; and 172
(75%) had dyslipemia.
The distribution of coronary lesions in the patients who under-
went a cardiac catheterization were: normal coronariography, 13
patients (10%); one vessel, 49 patients (37%); two vessels, 42
patients (32%); and three vessels, 28 patients (21%).
No differences were found in the prevalence of smoking habits
(93% of our patients were smokers) and diabetes in either group
(Tchol/HDL $5 vs. Tchol/HDL ,5) (3).
Nor were there any differences in the appearance of angina,
myocardial infarction, heart failure, mortality and the need for
coronary revascularization in the follow-up period. Significant data
are shown in Table 1.
We concluded that our patients, who were younger than 50
years of age, with ischemic heart disease, and who showed a
Tchol/HDL ratio #5, present less prevalence of hypertension and
show more frequently an absence of significant coronary lesions in
comparison with those patients with an altered lipid profile.
Furthermore, no additional benefits were found in relation to new
coronary events (fatal and nonfatal). We interpret that this lack of
benefit might be due to the high percentage of smokers in both
groups. Finally, our data are coincident with those reported
previously (4), showing that a normal lipid profile does not confer
additional benefit to smokers.
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REPLY
Batalla and colleagues found in a sample of 220 Spanish men with
coronary heart disease that frequencies of epsilon43 and epsilon44
genotypes did not differ from those among 200 age-matched
controls. In contrast, we observed in the Danish population (by
comparing genotype frequencies in 693 male patients with those
among 4,129 men sampled from the general population) that the
epsilon43 and epsilon44 genotypes compared with the wild-type
epsilon33 genotype in men predicted 40% and 60% increases in
risk of ischemic heart disease, respectively (1).
It is well established that there is a north-to-south decreasing
gradient of the epsilon4 allele frequency throughout Europe (2,3).
This is exemplified by an epsilon4 relative allele frequency of 17%
in the Danish population (1) versus 8% in the Spanish population,
as demonstrated by Batalla et al. We agree that the lower frequency
of the epsilon4 allele in Southern versus Northern Europe may
Table 1. Differences Between Normolipemic and
Hyperlipemic Patients
Tchol/HDL
<5 (n 5 39)
Tchol/HDL
>5 (n 5 190)
p
Value
Hypertension 7 (18%) 77 (40%) 0.007
Normal coronariography 6 (30%) 7 (6%) ,0.005
HDL 5 high density lipoprotein; Tchol 5 total cholesterol.
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partly explain the relatively lower incidence of ischemic heart
disease in Southern Europe; however, differences in genotpye fre-
quencies most likely cannot explain differences in associations between
genotype and risk of ischemic heart disease in different parts of the
world. Other possible explanations for such differences exist.
First, the apolipoprotein E polymorphism may act as a suscep-
tibility mutation for ischemic heart disease; such mutations need
certain contexts before their impact on risk of disease is expressed.
Perhaps a diet rich in saturated fat can explain part of a higher
prevalence in cardiovascular disease associated with the epsilon4
allele in Northern Europe compared with Southern Europe.
Second, as the study by Batalla et al. included only 220 patients
and 200 controls it is also possible that lack of power in that study
explains the negative findings: The power in that study given a
two-sided p value ,0.05 to exclude the 40% and 60% increases in
risk of ischemic heart disease associated with epsilon43 and
epsilon44 (as observed in our study), was only 30% and 10%,
respectively.
Finally, our observations of increased risk associated with
epsilon43 and epsilon44 genotypes could represent chance find-
ings. However, we find this unlikely because 1) epsilon43 and
epsilon44 were (in our study and many other studies) also
associated with increases in both cholesterol and triglyceride levels,
explaining the increased risk of ischemic heart disease, and 2) our
observations of increased risk of ischemic heart disease associated
with the epsilon4 allele in men agrees with that of a previous
meta-analysis including mainly men (4).
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Dispersion of Repolarization
During Induction and
Termination of Ventricular Fibrillation
I read with great interest the article by Moubarak et al. (1). The
authors found that a high postshock dispersion of repolarization
(PSDR) following a T-wave shock is associated with induction of
ventricular fibrillation (VF); although following a defibrillating
shock, it is associated with its failure and the continuation of VF.
However, the authors did not mention anything about the antiar-
rhythmic drugs (ADs) used by the patients. The drugs were not
specified and described in the study. We do not know whether the
patients who failed to induce VF with T-wave shock were taking
amiodarone. Amiodarone provides homogeneous prolongation of
ventricular repolarization (VR) and prevents the development of
reentrant circuits. During testing of the implantable cardioverter
defibrillator (ICD) it is sometimes very difficult to induce and
perpetuate VF with T-wave shock in patients taking amiodarone.
It is well known that different drugs, especially class 1A, class
1C, and class 3 prolong VR in a spatially heterogeneous manner,
which results in increased dispersion of VR (2). In a report about
propofol, which was used for general anesthesia during ICD
testing, it was mentioned that propofol decreased QT interval and
dispersion (3).
In light of these findings it is reasonable to suggest that different
ADs used by the patients in this study (1) might have caused
repolarization changes. We also have no idea about baseline QT
measurements. Some patients might have demonstrated high
baseline QT dispersions. Hence, patients taking amiodarone or
class 1 drugs might show high or low QT intervals and dispersion,
which might affect PSDR and inducibility as well as terminability
of VF. Thus, without knowing which patient took which drug and
baseline QT dispersions, it is not rational to attribute a high PSDR
to inducibility or terminability of VF.
Other factors such as disease state, transient ischemia, electro-
lyte abnormalities, changes in autonomic tone, and hemodynamic
stress may also modulate the PSDR and also the success rate of
shock attempts. It might be quite helpful to know the PSDR
between shock attempts in one patient, because PSDR can be
variable between shock attempts in one particular patient or among
different patients according to the factors mentioned above. In
other words, one can terminate or fail to terminate VF with the
same shock strength according to the probability nature of the
defibrillation success curve. It would be more reliable to withhold
the drugs at least five half-lives before the procedure to minimize
the potential effect of drugs on preshock and postshock repolar-
ization times.
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